For the past 23 years, MJFF has supported the Parkinson’s disease (PD) research community by funding research in PD biology, biomarkers, and preclinical through clinical therapeutic developments. Over the past 15 years, MJFF has also expanded our role in the PD research space to provide non-financial resources to align the field and speed new discoveries and developments. These resources include (1) biosamples from a number of PD clinical studies, (2) clinical, genetic, biologic, and patient-reported outcome data from PD clinical studies, and (3) preclinical tools such as antibodies, proteins, cell lines, viral vectors, rodent models, etc. Herein we provide an overview of the many resources MJFF makes available to the research community, with details on how to browse and access resources that are currently available. We provide insights into upcoming research tools that are currently in development for folks to understand what will be available in the future, a summary of iPSC lines available through PPMI, and recent additions to our datasets. Finally, we provide information on how to contact MJFF to ask questions about existing resources, provide feedback, and suggest additional resources MJFF could consider developing for the research community.